COMP <GO>
NX vs TMO // PIOTROSKI F-SCORE QUALITY
Quanex Building Products Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NX 3
— TMO 7
▲ PIOTROSKI F-SCORE QUALITY LEADER: TMO
LAST: $20.76 (+4.85%) • MKT CAP: $951.4M
piotroski-score
6/9
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.90% | 9.30% | -32.20 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.75% | 2.40% | +8.35 | NX | /fcf-yield <GO> |
| Operating Margin | -10.60% | 17.40% | -28.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | -13.60% | 15.10% | -28.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 43.80% | 3.90% | +39.90 | NX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.57% | 0.24% | +1.33 | NX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 4.50 | -3.13 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.0 | 62.9 | -4.86 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $951.4M | $262.22B | -$261.27B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NX REV | TMO REV | NX GROSS % | TMO GROSS % | NX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.84B | $44.56B | 27.2% | — | $102.3M | $6.29B |
| FY 2024 | $1.28B | $42.88B | 23.9% | — | $51.7M | $7.27B |
| FY 2023 | $1.13B | $42.86B | — | — | $147.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NX // BETA —
TMO // BETA 0.94